课题基金 / 基金详情

Increased expression of aryl hydrocarbon receptor in clear cell renal cell carcinoma and infiltrating lymphocytes: Implications for cancer invasion, prognosis and tumor immunity

Increased expression of aryl hydrocarbon receptor in clear cell renal cell carcinoma and infiltrating lymphocytes: Implications for cancer invasion, prognosis and tumor immunity
透明细胞肾细胞癌和浸润淋巴细胞中芳烃受体表达增加:对癌症侵袭、预后和肿瘤免疫的影响
批准号:
24791668
负责人:
ISHIDA Masaru
金额:
$2.75万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2012
资助国家:
日本
项目状态:
已结题
起止时间:
2012-04-01 至 2014-03-31

项目摘要

项目成果

ISHIDA Masaru的其他基金

相似基金

相关文献

中文摘要
翻译
肾癌组织中AhR与吸烟史、性别、组织学分级显著相关。AhR阳性TIL的数量与组织学分级和病理T分期显著相关。肿瘤组织中T细胞明显多于B细胞。在预后不良的患者中,辅助性T细胞的数量明显高于细胞毒性T细胞。癌旁组织中AhR阳性的TIL和调节性T细胞的浸润明显多于癌组织。TIL中AhR表达是无进展生存期的显著预测因子。多因素分析显示癌细胞AhR是影响无进展生存期和疾病特异性生存期的独立预后因素,提示AhR可能参与肿瘤免疫。
英文摘要
AhR in RCC was significantly associated with the smoking history, gender and histological grade. The number of AhR-positive TIL was significantly associated with histological grade and pathological T stage. In tumor tissues, the number of T cell was significantly higher than that of B cell. In the patients who have poor prognosis, the number of helper T cell was significantly higher than that of cytotoxic T cell. Furthermore, in those patients AhR-positive TIL and regulatory T cell more infiltrated in tumor adjacent tissues than in tumor tissues. The AhR expression in TIL was a significant predictor for progression free survival. A multivariate analysis revealed that AhR in cancer cells was an independent prognostic factor for the progression free survival and disease specific survival.These results suggest that AhR may be involved in tumor immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
慶應義塾大学医学部 泌尿器科学教室 業績紹介
庆应义塾大学医学院泌尿外科成果介绍
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Increased expression of aryl hydrocarbon receptor in clear cell renal cell carcinoma and infiltrating lymphocytes: Implications for cancer invasion, prognosis and tumor immunity
透明细胞肾细胞癌和浸润淋巴细胞中芳烃受体表达增加:对癌症侵袭、预后和肿瘤免疫的影响
DOI: --
发表时间: 2014
期刊:
影响因子: --
作者: [Ishida M, Mikami S, Kosaka T, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Okada Y, Oya M]
通讯作者: Oya M
DOI: 10.1158/1078-0432.ccr-12-0073
发表时间: 2012-08-01
期刊: CLINICAL CANCER RESEARCH
影响因子: 11.5
作者: [Miyazaki, Yasumasa, Kosaka, Takeo, Oya, Mototsugu]
通讯作者: Oya, Mototsugu
Increased expression of aryl hydrocarbon receptor in clear cell renal cell carcinoma and infiltrating lymphocytes : Implications for cancer invasion, prognosis and tumor immunity
透明细胞肾细胞癌和浸润淋巴细胞中芳烃受体表达增加:对癌症侵袭、预后和肿瘤免疫的影响
DOI: --
发表时间: 2014
期刊:
影响因子: --
作者: [Ishida M, Mikami S, Kosaka T, Mizuno R, Kikuchi E, Miyajima A, Nakagawa K, Okada Y, Oya M]
通讯作者: Oya M
Biological significance of expression of aryl hydrocarbon receptor in bladder cancer
  • 批准号:
    22791494
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $2.58万
  • 财政年份:
    2010
  • 负责人:
    ISHIDA Masaru
  • 依托单位:
Development of chromatography System for multi components with high-yield, high-purity, high-concentration and high-productivity
  • 批准号:
    15360409
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 资助金额:
    $6.66万
  • 财政年份:
    2003
  • 负责人:
    ISHIDA Masaru
  • 依托单位:
Development of High-performance Chemical-looping Combustion
  • 批准号:
    11555198
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 资助金额:
    $8.0万
  • 财政年份:
    1999
  • 负责人:
    ISHIDA Masaru
  • 依托单位:
Development of Combustor with CO_2 Capturing by Alternately Changing Fuel and Air Streams
  • 批准号:
    11450298
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
  • 资助金额:
    $8.64万
  • 财政年份:
    1999
  • 负责人:
    ISHIDA Masaru
  • 依托单位:
海外基金